Clinical Trials
458
Trial Phases
4 Phases
Drug Approvals
6
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (397 trials with phase data)• Click on a phase to view related trials
A Trial to Assess the Efficacy and Safety of TEV-53408 in Adults With Celiac Disease
- First Posted Date
- 2025-02-04
- Last Posted Date
- 2025-06-26
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D LLC
- Target Recruit Count
- 48
- Registration Number
- NCT06807463
- Locations
- 🇺🇸
Teva Investigational Site 12133, Marrero, Louisiana, United States
🇺🇸Teva Investigational Site 12131, Colorado Springs, Colorado, United States
🇺🇸Teva Investigational Site 12134, Inverness, Florida, United States
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older with Asthma
- Conditions
- Asthma
- First Posted Date
- 2025-06-04
- Last Posted Date
- 2025-06-10
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D Inc.
- Target Recruit Count
- 555
- Registration Number
- 2024-517991-39-00
- Locations
- 🇵🇱
Synexus Polska Sp. z o.o., Gdansk, Poland
🇵🇱Alergo-Med Specjalistyczna Przychodnia Lekarska Sp. z o.o., Tarnow, Poland
🇵🇱Santa Sp. z o.o., Lodz, Poland
Mass Balance Clinical Trial With TEV-56286
- First Posted Date
- 2024-10-04
- Last Posted Date
- 2025-01-29
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT06627231
- Locations
- 🇳🇱
Teva Investigational Site 38189, Groningen, Netherlands
A Trial to Test the Safety and Efficacy of TEV-53408 in Treating Vitiligo
- First Posted Date
- 2024-10-03
- Last Posted Date
- 2025-06-05
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Target Recruit Count
- 28
- Registration Number
- NCT06625177
- Locations
- 🇺🇸
Teva Investigational Site 12043, Scottsdale, Arizona, United States
🇺🇸Teva Investigational Site 12052, Hot Springs, Arkansas, United States
🇺🇸Teva Investigational Site 12044, Fremont, California, United States
A Multi-centered, Double-blind, Randomized, Placebo-controlled Study of TEV-56286 for the Treatment of Multiple System Atrophy
- Conditions
- Multiple System Atrophy
- First Posted Date
- 2024-04-16
- Last Posted Date
- 2025-05-26
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D LLC
- Target Recruit Count
- 103
- Registration Number
- 2023-505320-54-00
- Locations
- 🇫🇷
Assistance Publique Hopitaux De Paris, Paris Cedex 13, France
🇫🇷Centre Hospitalier Universitaire De Bordeaux, Bordeaux, France
🇫🇷Centre Hospitalier Universitaire De Toulouse, Toulouse, France
- Prev
- 1
- 2
- 3
- 4
- 5
- 44
- Next